Offer a low-cost renin-angiotensin-aldosterone system antagonist to people with CKD and diabetes and an ACR of 3 mg/mmol or more (ACR category A2 or A3). Offer a low-cost renin-angiotensin-aldosterone system antagonist to people with CKD and hypertension and an ACR of 30 mg/mmol or more (ACR category A3). Offer a low-cost renin-angiotensin-aldosterone system antagonist to people with CKD and an ACR of 70 mg/mmol or more (irrespective of hypertension or cardiovascular disease). Control blood pressure to targets of 120-139/<90 mmHg in people without diabetes with ACR < 70 mg/mmol. Control blood pressure to targets of 120-129/<80 mmHg in people with diabetes or with ACR >= 70 mg/mmol.
	
